ProCE Banner Activity


Key Updates on Hereditary Angioedema: CCO Independent Conference Coverage of the 2024 AAAAI Annual Meeting

Conference Coverage
Text Module

This expert-authored text module provides breaking research updates in the therapeutic landscape of hereditary angioedema as presented at the 2024 AAAAI Annual Meeting.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: March 22, 2024

Expiration: March 21, 2025



Marc Riedl

Marc Riedl, MD, MS

Clinical Director
US HAEA Angioedema Center
Professor of Medicine
Division of Allergy & Immunology
University of California, San Diego
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from CSL Behring LLC.

CSL Behring LLC

Target Audience

This program is intended for allergists, immunologists, internists, pediatricians, and nurse practitioners/physician associates who treat patients with hereditary angioedema.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Hereditary Angioneurotic Edema (HAE).

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key data presented at the 2024 AAAAI Annual Meeting on HAE

  • Translate key data on HAE presented at the 2024 AAAAI Annual Meeting to improvements in patient care and reduce unmet needs


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Marc Riedl, MD, MS

Clinical Director
US HAEA Angioedema Center
Professor of Medicine
Division of Allergy & Immunology
University of California, San Diego
La Jolla, California

Marc Riedl, MD, MS: researcher: Biocryst, Biomarin, CSL Behring, Ionis, Kalvista, Pharvaris, Takeda; consultant/advisor/speaker: Astria, Biocryst, Biomarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Ionis, Intellia, Kalvista, Novartis, Pfizer, Pharming, Pharvaris, Sanofi/Regeneron, Takeda.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose except Amanda Michaud, DMSc, PA-C, AE-C and Katherine Prince, FNP, as noted below:

Amanda Michaud, DMSc, PA-C, AE-C : consultant/advisor/speaker: Dermavant, Novartis, Pfizer, Regeneron.

Katherine Prince, FNPconsultant/advisor/speaker: CorEvitas LLC.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 22, 2024, through March 21, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until March 21, 2025. PAs should only claim credit commensurate with the extent of their participation.